Pharma Journalist -

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing transformative biologics such as vaccines and therapeutics for the world's most debilitating…
Read More...

Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for which no satisfactory treatments are…
Read More...

A collaboration among scientists from UCLA and other universities in California, Delaware and Germany, as well as a German pharmaceutical company, has singled out a compound that shows…
Read More...

Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, announced the successful closing of a EUR35 million Series B financing. New investors Hadean…
Read More...

Vertex Pharmaceuticals Incorporated announced that the Australian Therapeutic Goods Administration (TGA) has approved the use of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and…
Read More...

Exacis Biotherapeutics Inc., a development-stage immuno-oncology company working to democratize access to the most advanced and effective cancer treatments, announced several important…
Read More...

A broad coalition of biopharmaceutical and technology leaders announced a new strategic collaboration to promote new and updated standards for advanced therapies. The new collaboration,…
Read More...

Dunad Therapeutics emerges to develop next-generation small molecule therapeutics based on its highly differentiated, tuneable and targeted protein degradation technology. Dunad secured…
Read More...

Pfizer Inc. announced that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the…
Read More...

Sanofi has concluded an agreement to divest an integrated portfolio of its anti-inflammatory drugs to Fidia Farmaceutici, a privately-held company headquartered in Italy. This…
Read More...